Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-25 @ 1:26 AM
NCT ID:
NCT06710093
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven melanoma
* Unresectable stage III or stage IV disease, with confirmed radiological disease progression within 1 month of recruitment
* Patient has received at least 1 cycle of immunotherapy with checkpoint inhibitors for melanoma
* Undergoing standard of care active treatment with regular interval imaging or routine imaging surveillance following treatment completion/cessation
* Age over 16
* Not previously diagnosed with HIV, Hepatitis B or C (does not need testing)
Exclusion Criteria:
* Not on routine surveillance with interval imaging per standard of care
* Unable to provide informed consent due to psychological, medical or cognitive conditions.
* Unable to comply with schedule of study samples to be collected. Concurrent active malignancies needing treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT06710093
Study Brief:
Protocol Section:
NCT06710093